CERo Therapeutics Stock (NASDAQ:CEROW)
Previous Close
$0.01
52W Range
$0.01 - $0.01
50D Avg
$0.01
200D Avg
$0.02
Market Cap
$5.36M
Avg Vol (3M)
$117.41K
Beta
0.32
Div Yield
-
CEROW Company Profile
CERo Therapeutics Holdings, Inc., an immunotherapy company, focuses on advancing the development of engineered T cell therapeutics for the treatment of cancer. Its lead program in hematologic malignancies targets an Eat Me signal upregulated on B cell and myeloid tumors. The company is based in South San Francisco, California.